Prot # 10-392: ABSORB III Randomized Controlled Trial: Clinical Evaluation of BVS Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Project: Research project

Project Details

StatusActive
Effective start/end date6/25/13 → 6/25/25

Funding

  • Novella Clinical, LLC ((OE) Prot # 10-392)